231 related articles for article (PubMed ID: 32133362)
21. Autoimmune interstitial lung disease in Latin-America.
Vivero F; Campins F; Lancellotti D; Malfante P; Babini S; Sebastiani J; Basso V; Gaser A; Enghelmayer J; Gandara E;
Clin Immunol; 2019 Feb; 199():52-56. PubMed ID: 30543917
[TBL] [Abstract][Full Text] [Related]
22. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
[TBL] [Abstract][Full Text] [Related]
23. The Relationship Between Anti-SSA-52 and Interstitial Lung Disease.
Saunders H; Baig H; Li Y; White L; Hodge D; Lesser E; Stowell JT; Rojas CA; Mira-Avendano I
J Clin Rheumatol; 2024 Mar; ():. PubMed ID: 38446195
[TBL] [Abstract][Full Text] [Related]
24. [The clinical features and prognosis of interstitial lung disease patients with positive anti-neutrophil cytoplasmic antibody].
Gao C; Sun X; Huang J; Peng M; Sun XF; Zhang T; Shi JH
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):362-368. PubMed ID: 32294819
[No Abstract] [Full Text] [Related]
25. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
26. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
27. Interstitial lung disease evaluation: detecting connective tissue disease.
Fischer A; Lee JS; Cottin V
Respiration; 2015; 90(3):177-84. PubMed ID: 26343272
[TBL] [Abstract][Full Text] [Related]
28. Cross-disciplinary collaboration in connective tissue disease-related lung disease.
Fischer A; Richeldi L
Semin Respir Crit Care Med; 2014 Apr; 35(2):159-65. PubMed ID: 24668532
[TBL] [Abstract][Full Text] [Related]
29. Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.
Geerts S; Wuyts W; Langhe E; Lenaerts J; Yserbyt J
Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(4):326-335. PubMed ID: 32476865
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases.
Koslow M; Maleki-Fischbach M; Keith RC
Case Rep Rheumatol; 2021; 2021():6677353. PubMed ID: 33986967
[TBL] [Abstract][Full Text] [Related]
31. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
32. An analysis of the clinical features of lung cancer in patients with connective tissue diseases.
Saijo A; Hanibuchi M; Goto H; Toyoda Y; Tezuka T; Nishioka Y
Respir Investig; 2017 Mar; 55(2):153-160. PubMed ID: 28274531
[TBL] [Abstract][Full Text] [Related]
33. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features.
Pereira DA; Dias OM; Almeida GE; Araujo MS; Kawano-Dourado LB; Baldi BG; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(2):151-60. PubMed ID: 25972968
[TBL] [Abstract][Full Text] [Related]
34. Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review.
Solomon JJ; Fischer A
J Intensive Care Med; 2015 Oct; 30(7):392-400. PubMed ID: 24371251
[TBL] [Abstract][Full Text] [Related]
35. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
[No Abstract] [Full Text] [Related]
36. The Spectrum of Interstitial Lung Disease in Connective Tissue Disease.
Henry TS; Little BP; Veeraraghavan S; Bhalla S; Elicker BM
J Thorac Imaging; 2016 Mar; 31(2):65-77. PubMed ID: 26554660
[TBL] [Abstract][Full Text] [Related]
37. [Interstitial lung disease in connective tissue disorders].
Carmier D; Diot É; Guilleminault L; Marchand-Adam S
Rev Prat; 2014 Sep; 64(7):941-5. PubMed ID: 25362775
[TBL] [Abstract][Full Text] [Related]
38. Interstitial pneumonia with autoimmune features (IPAF) and radiological findings suggestive of lymphocytic interstitial pneumonia (LIP) - case report.
Płóciniczak A; Goździk-Spychalska J; Batura-Gabryel HB
Adv Respir Med; 2017; 85(1):46-50. PubMed ID: 28198994
[TBL] [Abstract][Full Text] [Related]
39. [Interstitial pneumonia with autoimmune features].
Nishiyama O; Tohda Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):139-144. PubMed ID: 28747599
[TBL] [Abstract][Full Text] [Related]
40. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).
Jee AS; Corte TJ
Drugs; 2019 Sep; 79(14):1511-1528. PubMed ID: 31399860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
